Encoded Monoclonal Antibody Therapy (Entos Pharmaceuticals)

N/A

Report date: 2024/09/02 11:12:48

Base Information

Drug NameEncoded Monoclonal Antibody Therapy (Entos Pharmaceuticals)
Drug Alias NameENTMAB001ENTMAB-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEntos Pharmaceuticals IncAegis Life Inc
China Registration ClassN/A

Develop Information

Active CompaniesAegis Life IncEntos Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A